特发性肺纤维化中靶向基质金属蛋白酶9的差异性反应
该研究探讨了抑制MMP9对特发性肺纤维化(IPF)的抗纤维化作用。在体外和体内实验中,抗MMP9抗体andecaliximab可阻断TGF-β1诱导的Smad2磷酸化,但部分IPF患者的ABC样细胞对MMP9阻断无反应或反应增强,且与1型IFN表达相关。在人源化免疫缺陷小鼠模型中,抑制MMP9仅改善由反应者肺细胞诱导的肺纤维化,提示靶向MMP9可能对1型IFN表达充分的IPF亚组患者有益。
要点
- IPF肺ABC样细胞中MMP9表达升高。
- andecaliximab阻断TGF-β1诱导的Smad2磷酸化。
- 部分IPF患者ABC样细胞对MMP9阻断无反应,与1型IFN表达相关。
核心结论
- MMP9调控IPF中ABC样细胞的活化,靶向MMP9可能对1型IFN表达充分的IPF亚组患者有益。
研究设计与样本
- 采用体外和体内的定量基因组学、蛋白质组学和功能分析。
- 使用人源化免疫缺陷小鼠IPF模型。
主要发现
- IPF肺ABC样细胞中MMP9表达较正常肺ABC细胞增加。
- andecaliximab阻断TGF-β1诱导的Smad2磷酸化。
- 部分IPF患者ABC样细胞中TGF-β1活化不受MMP9阻断影响或增强(无反应者)。
- 无反应者ABC样细胞经andecaliximab处理与1型IFN表达相关,添加IFNα可调节MMP9表达和TGF-β1活化。
- 抑制MMP9改善由反应者肺细胞而非无反应者诱导的肺纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Aberrant lung remodeling in idiopathic pulmonary fibrosis (IPF) is characterized by elevated MMP9 (matrix metalloproteinase 9) expression, but the precise role of this matrix metalloproteinase in this disease has yet to be fully elucidated.Objectives: To evaluate antifibrotic effects of MMP9 inhibition on IPF.Methods: Quantitative genomic, proteomic, and functional analyses both in vitro and in vivo were used to determine MMP9 expression in IPF cells and the effects of MMP9 inhibition on profibrotic mechanisms.Measurements and Main Results: In the present study, we demonstrate that MMP9 expression was increased in airway basal cell (ABC)-like cells from IPF lungs compared with ABC cells from normal lungs. The inhibition of MMP9 activity with an anti-MMP9 antibody, andecaliximab, blocked TGF-β1 (transforming growth factor β1)-induced Smad2 phosphorylation. However, in a subset of cells from patients with IPF, TGF-β1 activation in their ABC-like cells was unaffected or enhanced by MMP9 blockade (i.e., nonresponders). Further analysis of nonresponder ABC-like cells treated with andecaliximab revealed an association with type 1 IFN expression, and the addition of IFNα to these cells modulated both MMP9 expression and TGF-β1 activation. Finally, the inhibition of MMP9 ameliorated pulmonary fibrosis induced by responder lung cells but not a nonresponder in a humanized immunodeficient mouse model of IPF.Conclusions: Together, these data demonstrate that MMP9 regulates the activation of ABC-like cells in IPF and that targeting this MMP might be beneficial to a subset of patients with IPF who show sufficient expression of type 1 IFNs.
引用
- Espindola MS, Habiel DM, Coelho AL, et al. Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med. 2021. PMID: 33052708. doi:10.1164/rccm.201910-1977OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。